SynCore Biotechnology Co.,Ltd reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 5.79 million compared to TWD 4.48 million a year ago. Net loss was TWD 29.47 million compared to TWD 30.59 million a year ago. Basic loss per share from continuing operations was TWD 0.96 compared to TWD 1 a year ago.
For the nine months, sales was TWD 14.02 million compared to TWD 10.76 million a year ago. Net loss was TWD 79.79 million compared to TWD 106.93 million a year ago. Basic loss per share from continuing operations was TWD 2.6 compared to TWD 3.48 a year ago.